Unlocking the Potential of tDCS for Enhanced Cognition in Alzheimer’s Disease

Exciting New Research: tDCS Shown to Improve Cognitive Function in Alzheimer’s Patients

  • 124 patients with mild to moderate AD participated in the study
  • Active tDCS applied twice daily for 6 weeks
  • Improvements seen in memory-related cognitive functions
  • Electrophysiological evidence supports the potential of tDCS

“These results support the potential role of cortical plasticity as a biomarker of treatment effect in patients with AD,” the authors write.

Source: The study was published online in General Psychiatry on December 5. 

Limitations: No long-term follow-up was conducted to assess the duration of tDCS effectiveness. The study was supported by the Zhejiang Provincial Health Commission and other local funding sources. The authors have declared no competing interests. Read More

Latest articles

Related articles